↓ Skip to main content

Is the Harm-to-Benefit Ratio a Key Criterion in Vaccine Approval?

Overview of attention for article published in Frontiers in Medicine, July 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
2 news outlets
twitter
152 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Is the Harm-to-Benefit Ratio a Key Criterion in Vaccine Approval?
Published in
Frontiers in Medicine, July 2022
DOI 10.3389/fmed.2022.879120
Pubmed ID
Authors

Falk Mörl, Michael Günther, Robert Rockenfeller

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 152 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 38%
Professor 2 25%
Student > Master 1 13%
Unknown 2 25%
Readers by discipline Count As %
Nursing and Health Professions 1 13%
Agricultural and Biological Sciences 1 13%
Immunology and Microbiology 1 13%
Medicine and Dentistry 1 13%
Unknown 4 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 122. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 August 2024.
All research outputs
#369,583
of 26,614,447 outputs
Outputs from Frontiers in Medicine
#142
of 7,705 outputs
Outputs of similar age
#9,769
of 445,174 outputs
Outputs of similar age from Frontiers in Medicine
#10
of 586 outputs
Altmetric has tracked 26,614,447 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,705 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,174 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 586 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.